Dexcom (DXCM) Leases (2010 - 2026)

Dexcom (DXCM) has 12 years of Leases data on file, last reported at $73.1 million in Q1 2026.

• Quarterly Leases rose 23.69% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (up 23.69% YoY) and the FY2025 annual result came in at $77.4 million, up 23.25% from the prior year.
• Leases declined to $73.1 million in Q1 2026 per DXCM's latest filing, from $77.4 million in the prior quarter.
• Across five years, Leases topped out at $82.3 million in Q1 2022 and bottomed at $54.0 million in Q3 2025.
• The 5-year median for Leases is $73.1 million (2022), against an average of $70.7 million.
• The widest annual swing landed in 2025, when Leases declined 20.79%; it then rose 23.69% in 2026.
• Tracing DXCM's Leases over 5 years: stood at $80.0 million in 2022, then fell by 10.75% to $71.4 million in 2023, then declined by 12.04% to $62.8 million in 2024, then gained by 23.25% to $77.4 million in 2025, then retreated by 5.56% to $73.1 million in 2026.
• Per Business Quant, the three latest DXCM Leases figures stand at $73.1 million (Q1 2026), $77.4 million (Q4 2025), and $54.0 million (Q3 2025).

Peer Comparison